BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/26/2023 8:57:14 PM | Browse: 608 | Download: 1726
Publication Name World Journal of Clinical Cases
Manuscript ID 84095
Country Lithuania
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Case Report
Article Title Nivolumab-induced tumour-like gastritis: A case report
Manuscript Source Unsolicited Manuscript
All Author List Elena Cijauskaite, Edita Kazenaite, Sandra Strainiene, Benediktas Kurlinkus and Goda Sadauskaite
ORCID
Author(s) ORCID Number
Elena Cijauskaite http://orcid.org/0000-0002-1601-4760
Edita Kazenaite http://orcid.org/0000-0002-7127-1399
Sandra Strainiene http://orcid.org/0000-0003-1884-1353
Benediktas Kurlinkus http://orcid.org/0000-0001-9885-9347
Goda Sadauskaite http://orcid.org/0000-0001-5470-6154
Funding Agency and Grant Number
Corresponding Author Sandra Strainiene, MD, Attending Doctor, Department of Internal Medicine and Surgery, Antakalnis Clinic, Antakalnis Street 59, Vilnius 10207, Lithuania. sandra.strainiene@gmail.com
Key Words Nivolumab; Immune checkpoint inhibitors; Tumour-like gastritis; Proton pump inhibitors; Case report
Core Tip Nivolumab-induced gastritis is a less common immune-related adverse event of nivolumab. The most common symptoms include nausea, pain, diarrhea, loss of appetite, and weight loss. Esophagogastroduodenoscopy and biopsy are the most important diagnostic tools. In most cases, gastritis is treated with corticosteroids in combination with proton pump inhibitors. In our case, the patient was successfully treated with omeprazole monotherapy.
Publish Date 2023-06-26 20:57
Citation Cijauskaite E, Kazenaite E, Strainiene S, Sadauskaite G, Kurlinkus B. Nivolumab-induced tumour-like gastritis: A case report. World J Clin Cases 2023; 11(18): 4350-4359
URL https://www.wjgnet.com/2307-8960/full/v11/i18/4350.htm
DOI https://dx.doi.org/10.12998/wjcc.v11.i18.4350
Full Article (PDF) WJCC-11-4350-with-cover.pdf
Full Article (Word) WJCC-11-4350.docx